Voyager Therapeutics (VYGR) Net Cash Flow (QoQ) (2015 - 2026)
Voyager Therapeutics (VYGR) Net Cash Flow (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -227.11% |
| Dec 31, 2025 | 340.69% |
| Sep 30, 2025 | 112.74% |
| Jun 30, 2025 | -1,009.53% |
| Mar 31, 2025 | 108.23% |
| Dec 31, 2024 | -213.08% |
| Sep 30, 2024 | 154.36% |
| Jun 30, 2024 | -188.61% |
| Mar 31, 2024 | 2,038.64% |
| Dec 31, 2023 | 101.97% |
| Sep 30, 2023 | -647.49% |
| Jun 30, 2023 | -114.14% |
| Mar 31, 2023 | 7,968.70% |
| Dec 31, 2022 | -88.67% |
| Sep 30, 2022 | 134.44% |
| Jun 30, 2022 | -472.63% |
| Mar 31, 2022 | 142.36% |
| Dec 31, 2021 | 193.55% |
| Sep 30, 2021 | -14,253.33% |
| Jun 30, 2021 | -99.66% |